NEWS
Our Latest News
ARCHIMED acquires cell line development pioneer ExcellGene to accelerate expansion into biosimilars and high-performance transfection solutions
Global private equity healthcare specialist ARCHIMED acquires a majority stake in family-owned ExcellGene and sister company Magellan Biologics & Consulting (both in the biologic therapeutics sector), partnering with founders and management, to create a group covering gene transfer, cell line development and cell culture-based manufacturing for high-performance production of recombinant proteins, and other advanced therapeutics.
ARCHIMED expands neurodiagnostic business in Europe and the US
September
23,
2019
Bomi Group further expands in LATAM and completes the acquisition of ILS Corporation in Ecuador and Peru
August
14,
2019
ARCHIMED leads the management buyout of EUROLyser, a specialist in innovative Point-of-Care Testing
July
9,
2019
Italian dental clinics network Primo goes digital
June
6,
2019
368